Benzofuran Hybrids as Cholinesterase (AChE and BChE) Inhibitors: In Vitro, In Silico, and Kinetic Studies

[1]  A. Rehman,et al.  Potent α-amylase inhibitors and radical (DPPH and ABTS) scavengers based on benzofuran-2-yl(phenyl)methanone derivatives: Syntheses, in vitro, kinetics, and in silico studies. , 2020, Bioorganic chemistry.

[2]  M. Heravi,et al.  Total synthesis of natural products containing benzofuran rings , 2017 .

[3]  A. Hameed,et al.  Synthesis, structure-activity relationship and molecular docking of 3-oxoaurones and 3-thioaurones as acetylcholinesterase and butyrylcholinesterase inhibitors. , 2017, Bioorganic & medicinal chemistry.

[4]  L. Teh,et al.  Identification of novel acetylcholinesterase inhibitors: Indolopyrazoline derivatives and molecular docking studies. , 2016, Bioorganic chemistry.

[5]  J. Bajorath,et al.  One-pot synthesis of tetrazole-1,2,5,6-tetrahydronicotinonitriles and cholinesterase inhibition: Probing the plausible reaction mechanism via computational studies. , 2016, Bioorganic chemistry.

[6]  J. Bajorath,et al.  Syntheses, Cholinesterases Inhibition, and Molecular Docking Studies of Pyrido[2,3‐b]pyrazine Derivatives , 2015, Chemical biology & drug design.

[7]  Qurat-Ul-Ain,et al.  Synthesis, molecular docking, acetylcholinesterase and butyrylcholinesterase inhibitory potential of thiazole analogs as new inhibitors for Alzheimer disease. , 2015, Bioorganic chemistry.

[8]  F. J. Luque,et al.  1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies. , 2014, European journal of medicinal chemistry.

[9]  K. Dawood.  Benzofuran derivatives: a patent review , 2013, Expert opinion on therapeutic patents.

[10]  M. Pohanka.  Acetylcholinesterase inhibitors: a patent review (2008 – present) , 2012, Expert opinion on therapeutic patents.

[11]  U. Holzgrabe,et al.  Design, Synthesis and Evaluation of Novel 2‐(Aminoalkyl)‐isoindoline‐1,3‐dione Derivatives as Dual‐Binding Site Acetylcholinesterase Inhibitors , 2012, Archiv der Pharmazie.

[12]  M. Giovannini,et al.  Cholinesterase inhibitors and beyond. , 2009, Current Alzheimer research.

[13]  Yu Cheng,et al.  Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives. , 2008, Bioorganic & medicinal chemistry.

[14]  P. Carrupt,et al.  In vitro screening assays to identify natural or synthetic acetylcholinesterase inhibitors: thin layer chromatography versus microplate methods. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  F. J. Luque,et al.  Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease. , 2005, Journal of medicinal chemistry.

[16]  Jill M. Wetter,et al.  Synthesis and SAR of 5-amino- and 5-(aminomethyl)benzofuran histamine H3 receptor antagonists with improved potency. , 2005, Journal of medicinal chemistry.

[17]  J. Sussman,et al.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. , 2005, Current opinion in pharmacology.

[18]  Yvain Nicolet,et al.  Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products* , 2003, Journal of Biological Chemistry.

[19]  J. Buccafusco,et al.  The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development , 2003, Journal of Pharmacology and Experimental Therapeutics.

[20]  G. Kraus,et al.  Synthetic approach to malibatol A. , 2003, Organic letters.

[21]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[22]  E. Giacobini,et al.  Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit , 2002, Journal of Neural Transmission.

[23]  J. Trujillo,et al.  General behavior, toxicity, and cytotoxic activity of elenoside, a lignan from Justicia hyssopifolia. , 2001, Journal of natural products.

[24]  C. Guillou,et al.  Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts. , 2000, Bioorganic & medicinal chemistry letters.

[25]  F. J. Luque,et al.  Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease. , 1999, Journal of medicinal chemistry.

[26]  H. Lu,et al.  Anti-Oxidant Activity of Dibenzocyclooctene Lignans Isolated from Schisandraceae , 1992, Planta medica.

[27]  W. Moos,et al.  Drug development for senile cognitive decline. , 1986, Journal of medicinal chemistry.

[28]  K. Davis,et al.  Cholinergic approaches to the treatment of Alzheimer's disease. , 1986, British medical bulletin.

[29]  E von Angerer,et al.  2-Phenylindoles. Relationship between structure, estrogen receptor affinity, and mammary tumor inhibiting activity in the rat. , 1984, Journal of medicinal chemistry.

[30]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.